You are here:

Category: 3.4 Antihistamines hyposensitisation and allergic emergencies

Name SMC ID No Manufacturer Status Sub. Type
 
standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate 367/07 ALK-Abello Ltd Not Recommended Resubmission
icatibant (Firazyr) 476/08 Shire Pharmaceuticals Accepted Resubmission
standardised allergen extract of grass pollen from Timothy (Phleum pratense) 75,000 SQ-T per oral lyophilisate 367/07 ALK-Abello Ltd Not Recommended Full submission
adrenaline tartrate 150/300 micrograms solution for injection in pre-filled pen (Jext) 687/11 ALK-Abello Ltd Accepted Abbreviated Submission
omalizumab 75mg, 150mg solution for injection (Xolair) 708/11 Novartis Pharmaceuticals UK Ltd Superseded Abbreviated Submission
conestat (Ruconest) 745/11 Not Recommended Non submission
timothy grass pollen allergen (GRAZAX) 868/13 ALK-Abello Ltd Not Recommended Non submission
mepolizumab (Nucala) 1149/16 GlaxoSmithKline UK Ltd Restricted Full submission
omalizumab (Xolair) 1017/14 Novartis Pharmaceuticals UK Ltd Restricted Full submission
bilastine (Ilaxten®) 730/11 A Menarini Pharmaceuticals UK Ltd Not Recommended Non submission

Back